Simple dialysis change could save thousands of lives, major trial hints
NCT ID NCT04079582
First seen May 04, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This study looks at whether raising the magnesium level in the fluid used during dialysis can help people with end-stage kidney disease live longer and avoid heart-related hospital stays. Many dialysis patients have low magnesium, which is linked to higher risks of death, heart issues, and muscle cramps. The trial involves 25,000 patients across many dialysis centers, comparing standard magnesium levels to a higher one, to see if this simple, low-cost change improves health outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Health Sciences Centre
London, Ontario, N6A5W9, Canada
Conditions
Explore the condition pages connected to this study.